Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Identification and characterisation of bacteriocins from environmental samples active against strains of Clostridium difficile


   School of Life Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr C Penfold, Dr Klaus Winzer, Dr L Waddon  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Clostridium difficile is a cause of neonatal enteritis in livestock such as pigs, cattle and horses. Affected animals develop respiratory problems, abdominal distention and bloody diarrhoea leading to weight loss and in extreme cases mortality. This puts a financial burden on the farming industry, and a potential risk to healthcare if infected animals are not treated with appropriate antibiotics. Being an anaerobic spore former, C. difficile is resistant to many antibiotics and treatment is currently limited to only a few (metronidazole, vancomycin, fidaxomicin). Resistance to metronidazole has been observed already, exemplifying the urgent need for new therapies. One alternative option for successful treatment of CDI is the use of bacteriocin therapy. Bacteriocins are ribosomally synthesised protein antibiotics that kill closely related species to the producing micro-organism and have been shown to be important factors in the establishment of individual strains from mixed populations of E. coli, Pseudomonas aeruginosa and Klebsiella pneumoniae. Bacteriocins have recently been shown to be produced by Bacillus spp. with activity against a range of C. difficile isolates.

The aim of this project is to identify novel bacteriocins produced by clostridia and other bacteria from environmental samples that are likely to harbour bacteria in close association with C. difficile. Biological activity against a range of C. difficile strains including the hypervirulent PCR-ribotype 027 strains will be tested to identify candidate active organisms that can be characterised further to determine the mechanisms of bacteriocin import and activity against sensitive cells.

The work will involve enriching for bacterial colonies from the environmental samples and then replica plating and screening for bacteriocins active against strains of C. difficile by the presence of zones of inhibition around individual colonies on biological activity assay plates. The bacterial colonies will be identified using 16s rDNA sequencing and whole genome sequencing. Activity in cell free extracts will be tested to see if the active bacteriocin is actively secreted into the environment and stable in isolation. We have some preliminary data that suggests expressed bacteriocins have low activity in cell free extracts, but that activity can be significantly enhanced by ammonium sulphate concentration. Concentrated bacteriocins will be investigated further using SDS-PAGE and native PAGE to fractionate samples and allow gel-overlay experiments with sensitive bacterial to identify the active protein. Mass spectrometry of isolated protein bands will be used to identify the candidate protein bacteriocins. In silico analysis of the sequenced genome will allow identification of potential bacterial gene clusters responsible for the expressed active bacteriocin which can be characterised further by gene cloning, protein purification and targeted gene mutations using the well-developed CRISPR-Cas9 system available in the laboratory. Gene engineering may be possible to increase host-range and/or potency of the bacteriocin.

The University of Nottingham is one of the world’s most respected research-intensive universities, ranked 8th in the UK for research power (REF 2014). Students studying in the School of Life Sciences will have the opportunity to thrive in a vibrant, multidisciplinary environment, with expert supervision from leaders in their field, state-of-the-art facilities and strong links with industry. Students are closely monitored in terms of their personal and professional progression throughout their study period and are assigned academic mentors in addition to their supervisory team. The School provides structured training as a fundamental part of postgraduate personal development and our training programme enables students to develop skills across the four domains of the Vitae Researcher Development Framework (RDF). During their studies, students will also have the opportunity to attend and present at conferences around the world. The School puts strong emphasis on the promotion of postgraduate research with a 2-day annual PhD research symposium attended by all students, plus academic staff and invited speakers.

Funding Notes

Home applicants should contact the supervisor to determine the current funding status for this project. EU applicants should visit the Graduate School webpages for information on specific EU scholarships http://www.nottingham.ac.uk/GraduateSchool/index.aspx. International applicants should visit our International Research Scholarships page for information regarding fees and funding at the University http://www.nottingham.ac.uk/studywithus/international-applicants/scholarships-fees-and-finance/index.aspx.

References

Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C. (2010). Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A. 107(20):9352-7. doi: 10.1073/pnas.0913554107. Epub 2010 Apr 30.

Chikindas, M. L., Weeks, R., Drider, D., Chistyakov, V. A. and Dicks, L. M. (2018). Functions and emerging applications of bacteriocins. Current opinion in biotechnology. 49:23–28. doi: 10.1016/j.copbio.2017.07.011.

How good is research at University of Nottingham in Biological Sciences?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Where will I study?